GMZ2 Vaccine-Induced Antibody Responses, Naturally Acquired Immunity and the Incidence of Malaria in Burkinabe Children

GMZ2 is a malaria vaccine candidate evaluated in a phase 2b multi-centre trial. Here we assessed antibody responses and the association of naturally acquired immunity with incidence of malaria in one of the trial sites, Banfora in Burkina Faso. The analysis included 453 (GMZ2 = 230, rabies = 223) ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Dassah, Sylvester, Adu, Bright, Tiendrebeogo, Régis W., Singh, Susheel K., Arthur, Fareed K. N., Sirima, Sodiomon B., Theisen, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200992/
https://www.ncbi.nlm.nih.gov/pubmed/35720297
http://dx.doi.org/10.3389/fimmu.2022.899223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200992/
https://www.ncbi.nlm.nih.gov/pubmed/35720297
http://dx.doi.org/10.3389/fimmu.2022.899223

Ejemplares similares